OFG
AUPH icon

OTA Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

OTA Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-140,000
Closed -$2.84M – 46
2019
Q4 		$2.84M Buy
+140,000
New +$1.29M 1.89% 13

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OTA Financial Group's AUPH Position: Q3 2017 in Review

OTA Financial Group sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2017, closing a stake of 175,934 shares — an estimated $1.29M sold.

OTA Financial Group first reported a position in AUPH in Q1 2017 and held it in 2 quarters. The position peaked at $1.29M in Q2 2017. 62 funds tracked by Wall St. Rank hold AUPH as of Q3 2017.

  • OTA Financial Group reported no remaining Aurinia Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • OTA Financial Group sold 175,934 Aurinia Pharmaceuticals shares in Q3 2017, an estimated $1.29M.
  • OTA Financial Group first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • OTA Financial Group's Aurinia Pharmaceuticals position peaked at $1.29M in Q2 2017.
  • 62 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2017.

Based on OTA Financial Group's 13F filing for Q3 2017, filed 20 Oct 2017.